The p53 tumor suppressor protein plays a critical role in the regulation of the cell cycle and apoptosis. The importance of p53's functions is underscored by the high incidence of p53 mutations in human cancers. Recently, two p53-related proteins, p73 and p63, were identi®ed as members of the p53 gene family. Multiple isoforms of p73 have been found, including DN variants in which the N-termini are truncated. p63 is expressed as three major forms, p63a, p63b and p63g, each of which dier in their C-termini. All three forms can be alternatively transcribed from a cryptic promoter located within intron 3, producing DNp63a, DNp63b and DNp63g. The high degree of similarity of p73 and p63 to evolutionarily conserved regions of p53 suggests that these proteins play an important and potentially redundant role in regulating cell cycle arrest and apoptosis. Here we describe the characterization of cell lines generated to inducibly express p63a and DNp63a. We have found that p63a and DNp63a can dierentially regulate endogenous p53 target genes and induce cell cycle arrest and apoptosis. Deletion of the N-terminal 26 amino acids of DNp63a abolished its ability to transactivate p53 target genes and induce cell cycle arrest and apoptosis. This indicates that a putative transactivation domain exists within the N-terminus of the DN variants of p63. Furthermore, the dierential regulation of p53 target genes by p63a and DNp63a suggests that p63 and p53 utilize both similar and dierent signaling pathways to execute their cellular functions. Oncogene (2001) 20, 3193 ± 3205.
Introduction
More than 50% of all human cancers contain mutations in the p53 tumor suppressor gene (Hollstein et al., 1991 (Hollstein et al., , 1994 . In response to cellular stresses such as DNA damage and hypoxia, p53 is activated and can mediate cell cycle arrest and apoptosis via the upregulation of numerous target genes (for reviews, see Agarwal et al., 1998; Levine, 1997; Prives and Hall, 1999) . p21 WAF1 , a potent inducer of cell cycle arrest (elDeiry et al., 1993; Harper et al., 1993) , and Bax (Miyashita and Reed, 1995) and MCG10 (Zhu and Chen, 2000) , initiators of the apoptotic cascade, are p53 target genes. p53-null mice, as well as humans containing germline mutations at the p53 locus, are susceptible to spontaneous tumors (Donehower et al., 1992; Evans and Lozano, 1997) . The observation that p53-null mice maintain normal embryonic development (Donehower et al., 1992) , however, has raised the possibility that there exists a family of closely related proteins with overlapping functions. Recently, two new genes, TP73 and TRP63, have been found to encode several p73 and p63 proteins, respectively, with structures and functions related to p53 (for reviews, see Chen, 1999; Levrero et al., 2000; Lohrum and Vousden, 2000) . The ®rst p53 homolog described was p73 (Kaghad et al., 1997) . There are at least six isoforms of p73, most of which dier in the C-terminal region and have varied transcriptional activites (De Laurenzi et al., 1998 , 1999 Kaghad et al., 1997; Ueda et al., 1999; Zaika et al., 1999) . p73 shares considerable sequence identity with p53, reaching 63% within the DNAbinding domain and including highly conserved DNA contact residues frequently mutated in tumors (Kaghad et al., 1997) . Homology between p73 and p53 also exists within the N-terminal transactivation domains (29% identity) and the oligomerization domains (38% identity) (Kaghad et al., 1997) . p73 can bind to the p53 consensus DNA-binding motif and activate a number of p53-regulated genes, including p21 WAF1 (Jost et al., 1997; Zhu et al., 1998a) . p73 can also induce cell cycle arrest and apoptosis (Jost et al., 1997; Zhu et al., 1998a) . Accumulation and phosphorylation of p73 are seen in response to DNA damage; however, dierent DNA-damage inducers appear to have varied aects on p73 activation (Agami et al., 1999; Gong et al., 1999; Levrero et al., 1999; Shaul, 2000; Yuan et al., 1999) . The dierential regulation of p53 target genes by p73 indicates that although the activities of p53 and p73 overlap these two proteins also maintain separate and unique functions within a cell (Zhu et al., 1998a) . p73 proteins that lack the N-terminal transactivation domain have recently been found . These DNp73 proteins, although capable of binding p53 response elements, have been reported to be de®cient in transactivating a promoter that contains a p53 response element . Furthermore, DNp73 has been implicated as a dominant negative isoform of p73 .
More recently, a second p53 homolog, named p63, was described (Osada et al., 1998; Schmale and Bamberger, 1997; Senoo et al., 1998; Trink et al., 1998; Yang et al., 1998) . The TRP63 locus expresses three major forms, p63a, p63b and p63g, which, like p73, dier in the C-terminal region (Yang et al., 1998) . Each of these forms can be alternatively transcribed from a cryptic promoter located within intron 3, producing DNp63a, DNp63b and DNp63g (Yang et al., 1998) . Additionally, all six of these forms can exist as splicing variants in which four amino acids are deleted from exon 9 (Yang et al., 1998) . p63 contains regions of homology to p53 and shares 60% sequence identity with the DNA-binding domain, 22% identity with the N-terminal transactivation domain and 37% identity with the oligomerization domain of p53 (Osada et al., 1998) . p63g has been shown to transactivate reporter constructs containing p53 response elements derived from p53 target genes (Osada et al., 1998; Shimada et al., 1999; Yang et al., 1998) , as well as regulate endogenous p21 WAF1 expression (Osada et al., 1998) . In addition, overexpression of p63g can suppress growth and induce apoptosis (Osada et al., 1998; Yang et al., 1998) . In contrast to p53 and p73, p63 expression has been reported to be suppressed under conditions of DNA damage (Hall et al., 2000; Liefer et al., 2000) . P63 knockout mice exhibit major limb, craniofacial, and epithelial defects, indicating that p63 is critical for proper epithelial development (Mills et al., 1999; Yang et al., 1999) . The truncated DNp63 isoforms are thought to be transcriptionally inactive due to the lack of an acidic N-terminus corresponding to the transactivation domain of p53 (Yang et al., 1998) . the DNp63a and DNp63g variants have been reported to be functionally inactive in transactivating a promoter that contains a p53 response element and in inducing cell death (Yang et al., 1998) . Furthermore, the DNp63a and DNp63g isoforms have been shown to exhibit dominant-negative eects toward both p53 and p63 (Yang et al., 1998) , and DNp63 variants are thought to be oncogenic (Hibi et al., 2000) . However, many questions regarding the transactivation activities of the p63 isoforms have yet to be answered. Although p63g and p63a share identical N-terminal transactivation domains, p63g exhibits strong transactivation of promoters that contain p53 response elements and is a potent inducer of cell death, whereas p63a has no detectable transactivation activity (Yang et al., 1998) .
In this study, we generated stable p53-null, H1299 cell lines that inducibly express p63a and DNp63a under a tetracycline-regulated promoter. In contrast to previous reports, we have found that these p63 isoforms are transcriptionally active and dierentially regulate endogenous p53 target genes. In addition, we found that p63a and DNp63a are capable of inducing cell cycle arrest and apoptosis. These ®ndings indicate that a putative transactivation domain exists within the N-terminus of the DN variants of p63. Subsequent deletion of the N-terminal 26 amino acids of DNp63a abrogated the ability of this protein to regulate p53 target genes and induce cell cycle arrest and apoptosis. Furthermore, the dierential regulation of p53 and p73 target genes by p63 indicates that although the activities of p53-family members overlap, they also maintain separate and unique cellular functions.
Results

Generation of p63a-and DNp63a-expressing cell lines
Previously, several studies (Osada et al., 1998; Shimada et al., 1999; Yang et al., 1998) showed that p63g can induce apoptosis and p21
WAF1
, a cyclin-dependent kinase inhibitor that is primarily responsible for p53-dependent cell cycle arrest (el-Deiry et al., 1993; Harper et al., 1993) . However, p63a and the DN variants of p63 have been shown to be incapable of inducing apoptosis or p21 WAF1 (Yang et al., 1998) . To further determine the activity of p63a and DNp63a in the regulation of the cell cycle, we have generated H1299 non-small cell lung carcinoma cell lines that inducibly express these proteins under a tetracyclineregulated promoter. Two representative cell lines for both p63a and DNp63a are shown in Figure 1 . DNp63a-11 and DNp63a-22 expressed high levels of DNp63a protein, whereas p63a-11 and p63a-14 expressed moderate levels of p63a protein when induced (Figure 1, upper panel) . Interestingly, we found that p63a and DNp63a were able to induce p21 WAF1 ( Figure  1 , middle panel). The levels of actin were determined as a loading control (Figure 1 , lower panel).
p63 and p73 isoforms have been suggested to form homotypic and heterotypic complexes (Davison et al., 1999; Yang et al., 1998 ) that could potentially in¯uence activity of the inducible p63 in the above cell lines. To WAF1 (middle panel), and actin (lower panel) in p63a-11, p63a-14, DNp63a-11, and DNp63a-22 cell lines were assayed by Western blot analysis. Cell extracts were prepared from uninduced cells (7) and cells induced to express p63a or DNp63a (+) for 24 h. The upper portion of the blot was probed with anti-myc antibody 9E10.2, the middle portion of the blot was probed with anti-p21 antibody C19, and the lower portion of the blot was probed with anti-actin polyclonal antibody p63a and DNp63a variants of p63 are transcriptionally active M Dohn et al examine this possibility, we analysed the endogenous levels of these proteins in the parental H1299 cell line. As shown in Figure 2 , p63 isoforms were not detectable in H1299 cells; however, as previously shown (Yang et al., 1998) , DNp63a was detectable in the cervical carcinoma cell line ME-180 (Figure 2 ). p63 was detectable in p63a-11 and DNp63a-11 cell lines only when induced to express their respective p63 proteins, and DNp63a was found at levels less than that in ME-180 cells (Figure 2 , upper panel). The levels of actin were determined as a loading control ( Figure  2 , lower panel). Only the DNp63a isoform of p63 was detected in ME-180 cells, which is consistent with previous reports of predominant expression of DN variants (Crook et al., 2000; De Laurenzi et al., 2000; Hall et al., 2000; Yang et al., 1998) . Additionally, p73 was undetectable in the H1299 cell line (data not shown).
p63a and DNp63a can induce cell cycle arrest and apoptosis
To characterize the activity of p63, we analysed the eect of p63a and DNp63a expression on the growth rates of these cell lines. As shown in Figure 3 , expression of p63a and DNp63a suppressed cell proliferation. The uninduced cells (&) grew normally, whereas growth of p63a-and DNp63a-expressing cells (^) was severely diminished or nearly abolished up to 5 days after plating (Figure 3a ± d) . The growth rates of parental H1299 cells under induced and uninduced conditions were nearly identical (data not shown).
To determine whether the anti-proliferative eect of p63a and DNp63a was due to cell cycle arrest, apoptosis, or both, we used FACS analysis to examine the DNA content of p63-expressing cells. When p63 was not expressed, all four cell lines maintained similar cell cycle phase distributions of DNA content ( Figure  4a ,e,i,m). In contrast, when p63 was expressed, an increase in G 1 DNA content and a decrease in S phase DNA content were detected (Figure 4b Next, we performed a Trypan blue dye exclusion assay. As shown in Figure 5a , cells expressing p63a and DNp63a contained a consistently higher percentage of Trypan blue positive cells compared to those not expressing p63. This supports the above results and suggests that p63 can induce apoptosis. Additionally, we examined the eect of p63 expression on mitochondrial membrane potential. This assay utilizes¯uores-cence to distinguish between healthy and apoptotic cells. Induced and uninduced cells were stained with Mitosensor, a cationic dye. In healthy cells, the dye aggregates in the mitochondria and¯uoresces an intense red. Upon induction of apoptosis, changes in the cell's mitchondrial membrane potential prevent aggregation of the dye, resulting in a decrease in the mean¯uorescence. As shown in Figure 5b , expression of p63a and DNp63a resulted in a decrease in relative mean¯uorescence. p53-expressing cells were assayed as a positive control. The relative mean¯uorescence was similarly decreased in cells expressing p53, p63a, or DNp63a.
Differential regulation of p53 and p73 targets by p63
The high degree of similarity between p53, p73, and p63 DNA-binding domains, as well as the considerable similarity between the transactivation and oligomerization domains, led us to examine the ability of p63 to activate p53 and p73 target genes. We have found that some p53 and p73 target genes can be activated by p63a, DNp63a, or both, while others were not induced ( Figure 6 and data not shown). However, most genes that could be activated by p63 were only weakly induced ( Figure 6 ).
Previous reports have shown that p63g can transactivate p53 response elements within the p21 WAF1 promoter (Osada et al., 1998; Shimada et al., 1999) . and our data showed that endogenous p21 WAF1 transcript was induced when p63a was expressed, and DNp63a was able to weakly activate p21 WAF1 ( Figure  6a ). These results are consistent with the induction of Figure 2 H1299 cell line has undetectable levels of endogenous p63. Levels of p63 (upper panel) and actin (lower panel) in H1299, ME-180, p63a-11, and DNp63a-11 cell lines were assayed by Western blot analysis. Cell extracts were prepared from H1299, ME-180, and p63a-11 and DNp63a-11 that were uninduced (7) and induced (+) to express p63 for 24 h. The upper portion of the blot was probed with anti-p63 antibody Ab-1, and the lower portion was probed with anti-actin polyclonal antibody p21 WAF1 protein by p63a and DNp63a (see Figure 1) , as well as with the previous ®nding that endogenous p21 WAF1 can be induced by p63g in a transient transfection assay (Osada et al., 1998) .
Next we examined whether p63 can regulate the MDM2, GADD45, KILLER/DR5, BAX, p85, BTG2, and 14-3-3s genes. We found that MDM2, a negative regulator of p53 (Wu et al., 1993) , was weakly induced by p63a but not by DNp63a (Figure 6b) . Interestingly, the DNA damage responsive gene GADD45 (Kastan et al., 1992) was not activated by p63a but was highly induced by DNp63a (Figure 6c ). KILLER/DR5, a death receptor gene induced by genotoxic stress (Wu et al., 1997) , was weakly induced by DNp63a but not by p63a (Figure 6d) . BAX, an initiator of the apoptotic cascade (Miyashita and Reed, 1995) , and p85, a signal transducer in the cellular response to oxidative stress (Yin et al., 1998), were not induced by either p63a or DNp63a (data not shown). BTG2 and 14-3-3s, two p53-inducible genes involved in cell cycle arrest in G 2 (Hermeking et al., 1997; Rouault et al., 1996) , were not induced by either p63 isoform (data not shown).
We further examined whether p63 can regulate several redox-related p53-inducible genes (PIGs) . We found that PIG3 was strongly induced by p63a (Figure 6e ), and PIG8 was weakly induced by p63a (Figure 6f) . PIG6, PIG7, and PIG11 were not induced by p63a or DNp63a (data not shown). We did not analyse p63 induction of PIG10 and PIG12, which are not induced by p53 in H1299 cells (data not shown), and PIG1 and PIG4, which are undetectable in H1299 cells (data not shown).
To further examine the regulation of p53 target genes by p63a and DNp63a, we performed luciferase reporter assays. The promoter of the p53-target gene (a,b,e,f,i,j,m, and n) DNA content was quanti®ed by propidium iodide staining of ®xed cells from p63-expressing cell lines that were uninduced (7) or induced (+) to express p63a or DNp63a for 3 days. (c,d,g,h,k,l,o, and p) Apoptotic cells were quanti®ed by propidium iodide-annexin V staining of cells that were uninduced (7) or induced (+) to express p63a or DNp63a for 3 days Oncogene p63a and DNp63a variants of p63 are transcriptionally active M Dohn et al (Johansen and Prywes, 1994) . These resulting reporter constructs were cotransfected into H1299 cells with either a pcDNA3 control vector or a vector expressing p53, p63a, or DNp63a. We found that the luciferase activity of the p21 WAF1 and EphaA2 reporter constructs was signi®cantly increased when cotransfected with p53 ( Figure 7 ). Similarly, p63a was able to transactivate to p21 WAF1 reporter construct nearly ®vefold greater than a pcDNA3 control vector, and the EphA2 reporter construct was strongly transactivated by p63a ( Figure  7) . We found that similar to the Northern blot results in Figure 6a , DNp63a weakly transactivated the p21 WAF1 reporter construct (Figure 7) . Furthermore, DNp63a increased the luciferase activity of the EphA2 reporter construct nearly fourfold greater than a pcDNA3 control vector (Figure 7 ). -14) , or DNp63a (DNp63a-22) for 3 days were stained with a mitochondrial staining reagent as described in Materials and methods. A decrease in the relative¯uorescence is indicative of an increase in apoptosis Figure 6 p63a and DNp63a dierentially activate some but not all of the selected p53 and p73 target genes. Northern blots were prepared using 10 mg of total RNA isolated from p53-3, p73a-22, p73b-9, p63a-14, or DNp63a-22 cells under both the uninduced (7) and induced (+) conditions for 24 h. The blots were probed with cDNAs corresponding to the genes as indicated to the right of each blot, and mRNA levels were normalized to GAPDH (g). The fold increase in mRNA expression is shown below each blot
The N-terminal 26 amino acids are necessary for DNp63a activity
Although the DNp63a isoform lacks the N-terminal transactivation domain (Yang et al., 1998) , it retains the ability to regulate some p53 target genes and induce cell cycle arrest and apoptosis (see Figures 4 ±  7) . This indicates that a potential second transactivation domain exists within this p63 isoform. In an attempt to further de®ne this domain, we generated a DNp63a N-terminal deletion mutant (Table 1) . This protein, called DDNp63a, lacks the N-terminal 26 amino acids of DNp63a and was myc-tagged at the N-terminus, similarly to p63a and DNp63a. A representative cell line, which inducibly expresses DDNp63a under a tetracycline-regulated promoter, is shown in Figure 8a . DDNp63a protein was expressed (+) in the DDNp63a-16 cell line (Figure 8a , upper panel) at a level comparable to the p63a-expressing cell lines (data not shown). To determine whether DDNp63a has transcriptional activity, we analysed p21 WAF1 levels in this cell line. We found that unlike p63a and DNp63a, DDp63a was incapable of inducing p21 WAF1 expression (Figure 8a , middle panel).
To further characterize the activity of DDNp63a, we examined its eect on the growth rate of this cell line. As shown in Figure 8b , cells that were induced to express DDNp63a(^) grew at a rate similar to that of uninduced cells (&). In addition, there was no signi®cant increase in the number of G 1 or sub-G 1 cells when DDNp63a was induced (Figure 8d ) as compared to that of uninduced cells (Figure 8c) . Consistent with the DNA histogram analysis, the annexin V staining assay showed that the number of annexin V positive cells was not increased in cells induced to express DDNp63a (data not shown). Furthermore, there was no signi®cant dierence in the number of Trypan blue stained cells when induced (+) to express DDNp63a (Figure 8e ). Since the DNAdamage responsive gene GADD45 is strongly induced by DNp63a (see Figure 6c) , we determined whether GADD45 is regulated by DDNp63a. We found that unlike DNp63a, the DDNp63a deletion mutant was incapable of inducing GADD45 (Figure 9 ). These results suggest that DDNp63a is inactive in transactivation and is inert in inducing apoptosis and cell cycle arrest. The activities of p63a, DNp63a, and DDNp63a are summarized in Table 1 . WAF1 promoter that contains two p53 response elements was cloned upstream of a ®re¯y luciferase reporter gene, and a p53 response element found in the EphA2 promoter was cloned upstream of the c-fos minimal promoter and a ®re¯y luciferase reporter gene. The resulting reporter constructs were cotransfected into H1299 cells with either pcDNA3 empty vector control or a vector expressing p53, p63a, or DNp63a. The ®re¯y luciferase activity was measured from three dierent experiments and normalized with constitutive expression of Renilla luciferase 
Discussion
We have described here the characterization of H1299 cell lines that inducibly express p63a and DNp63a. We have demonstrated that both p63 isoforms are able to transactivate p53 target genes and induce cell cycle arrest and apoptosis. Deletion of the N-terminal 26 amino acids of DNp63a abolishes its ability to transactivate p53 targets and to induce cell cycle arrest and apoptosis, suggesting that a transactivation domain exists within this N-terminal region. Although p63 is homologous to p53 within highly conserved domains, p63 dierentially activates some but not all p53 and p73 target genes, indicating that p63 has cellular activities that are both similar to and dierent from those of the other p53 family members. Since DN isoforms of p63 lack the acidic N-terminus corresponding to the transactivation domain of p53, it has been proposed that these isoforms are transcriptionally inactive and act as dominant negative isoforms (Yang et al., 1998) . Here we present evidence that both p63a and DNp63a can activate p21
WAF1
, although p63a is a stronger inducer of p21 WAF1 than DNp63a ( Figure  6a ). It is likely that at low doses of a weak transactivator, the purported heterotypic interactions between p63 isoforms may serve to stabilize transactivation-capable variants. At higher doses of a weak transactivator, however, competition for p53 targets and sequestration of transactivating variants will result in an overall decrease in transactivation. This may explain the initial increase in transactivation activity of p63g when coexpressed with low levels of DNp63g, followed by a decrease in activity with high levels of DNp63g (Yang et al., 1998) . Therefore, heterotypic interactions between p63 isoforms may serve to either stabilize or inhibit transactivation activity in a concentration-dependent manner. The eect of heterotypic interactions on transactivation activity appears to be isotype-and target-speci®c and is underscored by the dierential regulation of p53 target genes by p63 isoforms (see Figure 6 ).
Deletion of the N-terminal 26 amino acids from DNp63a produced the mutant DDNp63a, which is incapable of regulating p53 target genes or of inducing cell cycle arrest and apoptosis (see Table 1 ). This suggests that a second transactivation domain exists within the N-terminus of DN isoforms of p63. This is not surprising, as two transactivation domains have previously been found within the p53 N-terminus (Candau et al., 1997; Zhu et al., 1998b) . It is highly unlikely that the myc epitope located at the N-termini of these p63 proteins is contributing to this activity, since DDNp63a lacks transactivation activity but retains the myc epitope. Further studies need to be conducted to more precisely map the activation domains of p63.
Our data provide evidence that p63-dependent arrest occurs predominantly in G 1 , similarly to that of p53. Both p63a and DNp63a were able to transactivate p21 WAF1 , although to a lesser extent than p53 ( Figure  6a ). The cyclin-dependent kinase inhibitor p21 WAF1 is known for its role in inducing cell cycle arrest in G 1 (el-Deiry et al., 1993; Harper et al., 1993) ; however, it remains to be seen whether the weak activation of p21 WAF1 by p63 is sucient to induce cell cycle arrest or whether additional genes are also involved in p63-mediated cell cycle arrest.
p53-dependent G 2 -M arrest is mediated in part by the DNA-damage inducible genes GADD45, BTG2, and 14-3-3s (Hermeking et al., 1997; Kastan et al., 1992; Rouault et al., 1996) . GADD45 has been shown to bind proliferating cell nuclear antigen and induce G 2 -M arrest in part by inhibiting Cdc2 protein kinase activity (Jin et al., 2000; Zhan et al., 1999) . As shown in Figure 6c , GADD45 was highly induced by DNp63a but not by p63a. The predominant G 1 arrest observed during p63 expression (see Figure 4 ) may limit the number of cells entering the G 2 -M phase, thus accounting for the lack of substantial increase in G 2 -M cells during DNp63a expression. Furthermore, BTG2 and 14-3-3s, two genes implicated in G 2 -M arrest (Chan et al., 1999; Rouault et al., 1996) , were not induced by either p63a or DNp63a (data not shown). This lack of induction of BTG2 and 14-3-3s correlates with the absence of a predominant p63-dependent G 2 -M arrest in H1299 cells.
It has previously been reported that p63a and DNp63a failed to transactivate the minimal p53-binding sequence PG-13 (Kern et al., 1992) within a b-galactosidase reporter construct (Yang et al., 1998) . This is not surprising and is consistent with our observation that p63a and DNp63a can induce some but not all endogenous p53 target genes (see Figure 6 ). In addition, it is well established that the activation of transfected promoter constructs does not always re¯ect the activation of endogenous genes where chromatin remodeling occurs (Smith and Hager, 1997) . The chromatin structure of these endogenous p53 target genes may aect p63-mediated transcription.
However, the induction of GADD45 by DNp63a, but not by p63a, is surprising. This disparity in transactivation indicates that the N-terminal domain absent in the Figure 9 DDNp63a cannot regulate the DNp63a target GADD45. Northern blots were prepared using 10 mg of total RNA isolated from p53-3, p63a-14, DNp63a-22, or DDNp63a-16 cells under both the uninduced (7) and induced (+) conditions for 24 h. The blots were probed with GADD45 cDNA (upper panel) and GAPDH cDNA (lower panel). The fold increase in mRNA expression is shown. ND, not done DNp63a isoform may inhibit p63a-mediated activation of certain genes. The N-terminus of p63a may confer steric hindrance such that it cannot bind and/or activate the GADD45 promoter. Perhaps interactions between the N-terminus of p63a and additional proteins reduce the transcriptional activity of p63. p53, p73, and KET, the rat homolog of p63a, have been shown to interact with Wilms Tumor 1 (WT1) protein (Maheswaran et al., 1993; Scharnhorst et al., 2000) , and WT1 can negatively modulate the transcriptional activity of both p53 and p73 (Maheswaran et al., 1993 (Maheswaran et al., , 1995 Scharnhorst et al., 2000) . It is likely that WT1 can also inhibit the activity of p63a to transactivate GADD45. Although the binding domain(s) of WT1 on p53 family members is not known, the truncated N-termini of DNp63 variants may prevent interaction with, and regulation by, WT1 or other proteins that may modulate p63 activity. p63a and DNp63a have been reported to be incapable of inducing apoptosis in transient transfection assays (Yang et al., 1998) . Because these assays were conducted with transiently transfected cells, the long-term eects of p63a and DNp63a activity were not detectable. As shown in Figure 3 , noticeable cell death did not occur until 2 ± 3 days post-induction of p63a and DNp63a. This suggests that although the p63g isoform can induce apoptosis within 16 h (Yang et al., 1998) , p63a-and DNp63a-mediated apoptosis is a late occurring event. This is supported by the lack of p73a-and p73b-mediated apoptosis in identical transient transfection assays (Yang et al., 1998) , whereas longterm expression of these p73 isoforms results in profound cell death (Zhu et al., 1998a) .
Although both p63a and DNp63a can induce apoptosis, the dierential regulation of p53 target genes indicates that the signaling pathways that lead to apoptosis dier from that of p53. Several genes involved in p53-dependent apoptosis (PIG6, PIG7 and PIG11) were not signi®cantly induced by p63a or DNp63a (data not shown), whereas PIG3 was strongly induced by p63a (Figure 6f ). PIG8, which has been shown to induce apoptosis (Gu et al., 2000) , was weakly induced by p63a but not by DNp63a ( Figure  6g ). p85, an apoptotic signal transducer in the cellular response to oxidative stress (Yin et al., 1998) , was not induced by p63a or DNp63a (data not shown). The DNA-damage inducible KILLER/DR5 gene may mediate p53-dependent apoptosis (Wu et al., 1997) , and it was weakly induced by DNp63a, but not by p63a (Figure 6e) MDM2, an oncogene that negatively regulates p53 activity (Wu et al., 1993) , was weakly activated by p63a but not by DNp63a (Figure 6b ). Physical interaction between MDM2 and the N-terminus of p53 inhibits the transactivation activity of p53 and enhances the degradation of p53 through the ubiquitination pathway (Haupt et al., 1997; Kubbutat et al., 1997; Oliner et al., 1993) . Although it is unclear whether p63 physically interacts with MDM2, activation of the oncogene by p63a suggests that this isoform is regulated by a similar mechanism as p53. The Nterminal truncation found in the DN isoforms may prevent interaction with MDM2. In addition, MDM2 was not activated by DNp63a. Therefore, the predominant expression of DN isoforms in epithelial tissues (Crook et al., 2000; De Laurenzi et al., 2000; Hall et al., 2000; Yang et al., 1998) may result from the lack of negative regulation by MDM2.
As shown in Figure 2 , the p63-expressing cell lines express lower levels of p63 than the ME-180 cell line. However, in contrast to H1299 cells, proliferation of ME-180 cells does not appear to be inhibited by p63. This may be due to genetic aberrations within the ME-180 cell line that render the cells insensitive to p63. The presence of human papilloma virus (HPV) DNA in the ME-180 cell line suggests that disruption of the pRb and p53 pathways by E7 and E6 proteins (Boyer et al., 1996; Schener et al., 1993) , respectively, may serve to immortalize these cells and diminish the anti-proliferative activity of p63 (for reviews, see Barbosa, 1996; zur Hausen, 2000) . Furthermore, attempts to clone p63 from ME-180 cells have yielded cDNAs with mutations resulting in an altered amino acid composition that could potentially aect p63 activity (data not shown).
Our data indicate that p63a and, more importantly, DNp63a are transcriptionally active and can induce cell cycle arrest and apoptosis. Our results emphasize the need to reassess the activities and functions of DN variants of p63 and possibly of p73. It is not yet determined whether p63 is a true tumor suppressor like its sibling p53; however, the ability of p63 isoforms to dierentially regulate p53 target genes and execute similar functions suggests that at least some signaling pathways are utilized by all members of the p53 family.
Materials and methods
Plasmids and mutagenesis
cDNAs from p63a and DNp63a (kindly provided by C DiComo and C Prives) were cloned separately into a tetracycline-regulated expression vector, pUHD10-3, at its BamHI site, and the resulting plasmids were used to generate cell lines that inducibly express p63. p63 proteins were tagged at their N-termini with a myc epitope. The mutant DDNp63a construct (see Table 1 ) was generated by PCR. The DNp63a cDNA was ampli®ed by a 5 primer (5'-GAT CGG ATC CAC CAT GGG CGA GCA GAA GCT CAT CTC AGA AGA AGA CCT CGA AGA CCA GCA GAT TCA G-3') and by a 3 primer (5'-GTC TGT TCA TTC CTC CGA CGC A-3') designed to incorporate a myc-tag at the N-terminus and eliminate the ®rst 26 codons of DNp63a. The resulting cDNA fragment was used to replace the 5' region of DNp63a between the BamHI and EcoRI sites.
Cell culture and cell lines
H1299 is a p53-null non-small cell lung carcinoma cell line. Cells were cultured in Dulbecco's Modi®ed Eagle's Medium with 10% fetal bovine serum. H1299 cell lines that inducibly p63a and DNp63a variants of p63 are transcriptionally active M Dohn et al express p63 were generated as described previously (Chen et al., 1996) . Individual clones were screened for inducible expression of p63 protein by Western blot analysis using antimyc epitope monoclonal antibody 9E10.2. The H1299 cell lines that inducibly express wild-type p53, p73a, and p73b are p53-3, p73a-22, and p73b-9, respectively, as described previously (Chen et al., 1996; Zhu et al., 1998a) . The human cervical carcinoma cell line ME-180 was purchased from American Type Culture Collection (Rockville, MD, USA).
Western blot analysis
Cells were washed and collected from plates in phosphatebuered saline (PBS) solution, resuspended with 26sample buer and boiled for 5 min. Western blot analysis was performed as described previously (Chen et al., 1996) . Anity puri®ed anti-actin polyclonal antibody was purchased from Sigma Chemical Co. (St. Louis, MO, USA). 9E10.2 was purchased from American Type Culture Collection (Rockville, MD, USA). Anti-p21 antibody C19 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-p63 monoclonal antibody Ab-1 was purchased from Oncogene Research Products (Cambridge, MA, USA).
Growth rate analysis
Cells were seeded at approximately 7.0610 4 cells/60-mm plate with or without tetracycline (1.0 mg/ml). The medium was replaced every 72 h. At the times indicated, two plates were rinsed with PBS twice to remove dead cells and debris. Live cells on the plates were trypsinized and collected separately. Cells from each plate were counted four times using a Coulter cell counter, and the average number of cells from both plates was used for growth rate determination.
FACS analysis
Cells were seeded at 2.0610 5 /90-mm plate, with or without tetracycline (1.0 mg/ml). Three days after plating, both oating dead cells in the medium and live cells on the plate were collected and ®xed with 1 ml of 75% ethanol for at least 1 h at 48C. The ®xed cells were centrifuged and resuspended in 0.5 ml PBS solution containing 20 mg/ml of RNase A (Sigma Chemical Co., St. Louis, MO, USA) and 50 mg/ml of propidium iodide (Sigma Chemical Co., St. Louis, MO, USA). The stained cells were analysed in a¯uorescence-activated cell sorter (FACSCaliber; Becton Dickinson, Menlo Park, CA, USA) within 4 h. The percentage of apoptotic cells containing a sub-G 1 DNA content was quanti®ed using the CellQuest program. The percentage of live cells in the G 0 ± G 1 , S, and G 2 -M phases was quanti®ed using the ModFit program.
Annexin V staining assay
The annexin V staining assay for apoptosis is based on the ability of annexin V to bind to phosphatidylserine. In healthy cells, phosphatidylserine is located on the inner lea¯et of the plasma membrane (Vermes et al., 1995) . Upon induction of apoptosis, phosphatidylserine can¯ip to the outer surface of the plasma membrane and bind annexin V (Vermes et al., 1995) , which is labeled with a¯uorescent dye and can be detected by FACS analysis. Both dead and live cells were collected and washed twice with cold PBS. The cells were resuspended in 0.1 ml of annexin V binding buer to a density of 1610 6 /ml and stained according to the manufacturer's instructions (Boehringer Mannheim, Germany).
Trypan blue dye exclusion
Trypan blue dye staining is based on the principle that certain dyes will not stain live, viable cells, whereas dead, unviable cells are susceptible to staining. Cells were seeded at approximately 7.0610 4 cells/60-mm plate with or without tetracycline (1.0 mg/ml). Three days after plating, live and dead cells from two plates were collected separately and mixed with an equal volume of 0.4% Trypan blue dye solution (Sigma Chemical Co., St. Louis, MO, USA) for 15 min. Stained (dead) and unstained (live) cells were counted using a hemocytometer and the percentage of dead cells/total cells was determined by scoring an average of over 300 cells, twice per plate.
Mitochondrial membrane assay
Cells were seeded at 2.0610 5 /90-mm plate, with or without tetracycline (1.0 mg/ml). Three days after plating, both oating dead cells in the medium and live cells on the plate were collected and stained with MitoSensor reagent (Clontech, Palo Alto, CA, USA) for 20 min at 378C before analysis by¯ow cytometry.
Luciferase assay
The p21 WAF1 promoter was cloned upstream of a luciferase reporter gene (Chinery et al., 1997) . The p53 response element found within the EphA2 promoter (Dohn et al., 2001, unpublished results) was cloned upstream of a minimal c-fos promoter and a ®re¯y luciferase gene (Johansen and Prywes, 1994) . 1.0 mg of the resulting reporter vectors was cotransfected into H1299 cells with 2.0 mg of pcDNA3 control vector or a vector expressing p53, p63a, or DNp63a. For an internal control, 25 ng of the Renilla luciferase vector pRL-CMV (Promgea, Madison, WI, USA) were cotransfected with the above constructs. Transfections were performed as described (Chen and Okayama, 1987) , and dual luciferase assays were performed in triplicate according to the manufacturer's instructions (Promega, Madison, WI, USA).
RNA isolation and Northern blot analysis
Total RNA was isolated from cells using Trizol reagents (Life Technologies, Inc., Gathersburg, MD, USA). Northern blot analysis was performed as described (Zhu et al., 1998b) . The p21 WAF1 , MDM2, BAX, GADD45, and GAPDH probes were prepared as described previously (Zhu et al., 1998b) . The KILLER/DR5 cDNA probe (GenBank #159553) was purchased from American Type Culture Collection (Rockville, MD, USA). The following cDNA probes were purchased from Genome Systems, Inc. (St. Louis, MO, USA): BTG2 (GenBank #H86711), 14-3-3s (W79136), PIG2 (H18355), PIG3(N75824), PIG6 (R88591), PIG7 (H98066), PIG8 (R42786), PIG11 (R54648), and p85 (N21330). 
